AMERICA HOLDINGS (NYSE:LH) Files An 8-K Regulation FD DisclosureItem 7.01
Regulation FD Disclosure
Summary information of the Company dated January 10, 2017.
About AMERICA HOLDINGS (NYSE:LH) Laboratory Corporation of America Holdings is a healthcare diagnostics company. The Company, together with its subsidiaries, is engaged in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The Company’s LCD segment is an independent clinical laboratory business that consists of a network of approximately 40 primary laboratories and approximately 1,700 patient service centers (PSCs) along with a network of branches and STAT laboratories, which offer a menu of routine and frequently ordered tests. LCD offers a menu of over 4,700 tests, such as blood chemistry analyses, urinalyses, blood cell counts and thyroid tests. Its CDD segment offers drug development services, and provides a range of drug development solutions across the world, primarily to companies in the pharmaceutical and biotechnology industries. AMERICA HOLDINGS (NYSE:LH) Recent Trading Information AMERICA HOLDINGS (NYSE:LH) closed its last trading session up +1.33 at 132.06 with 657,955 shares trading hands.